Avenue Therapeutics Inc. (NASDAQ: ATXI)
$3.57
+0.0800 ( +2.29% ) 3.4K
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.
Market Data
Open
$3.57
Previous close
$3.49
Volume
3.4K
Market cap
$3.25M
Day range
$3.45 - $3.72
52 week range
$3.21 - $91.50
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 18, 2024 |
10-k | Annual reports | 66 | Mar 18, 2024 |
def | Proxies and info statements | 2 | Mar 18, 2024 |
8-k | 8K-related | 14 | Mar 15, 2024 |
pre | Proxies and info statements | 2 | Mar 08, 2024 |
8-k | 8K-related | 14 | Mar 08, 2024 |
8-k | 8K-related | 15 | Feb 23, 2024 |
def | Proxies and info statements | 2 | Jan 29, 2024 |
pre | Proxies and info statements | 2 | Jan 17, 2024 |
8-k | 8K-related | 12 | Jan 12, 2024 |